Septic arthritis

1. High-Yield Summary

• True Orthopaedic Emergency: Acute native joint septic arthritis is a surgical emergency characterized by rapid, irreversible enzymatic chondrocyte destruction occurring within 24 to 48 hours of bacterial proliferation. Immediate joint decompression and targeted bactericidal antimicrobial therapy are required to prevent permanent joint destruction and systemic sepsis.
• Diagnostic Benchmarks: Arthrocentesis is the definitive diagnostic gold standard and must be performed prior to antimicrobial administration unless the patient is in hemodynamic septic shock. Synovial leukocyte count > 50,000/μL (likelihood ratio 7.7) and polymorphonuclear (PMN) differential ≥ 90% (likelihood ratio 3.4) strongly indicate septic arthritis; a count > 100,000/μL yields a likelihood ratio of 28.0.
• The Clinical Fallacy: Normal peripheral white blood cell count (36% specificity) and the absence of classic rigors or high fever (only 57% sensitivity) do not rule out septic arthritis, particularly in elderly, diabetic, or immunosuppressed hosts.
• Crystalline Coexistence: Identification of monosodium urate or calcium pyrophosphate dihydrate crystals on polarized light microscopy does not exclude concomitant infection; true crystal-pathogen co-infection occurs in 5% to 10% of presentations.
• Surgical Decompression Mandate: Arthroscopic lavage is the preferred primary modality for knee, shoulder, and ankle infections (Gächter Stages I–III), whereas open arthrotomy is mandatory for pediatric hip infections, Gächter Stage IV disease with bony extension, and failed prior arthroscopy.
• Antimicrobial Paradigm Shift: Following initial surgical decompression and 1 to 2 weeks of intravenous induction, sequential transition to highly bioavailable oral antimicrobials achieves non-inferior clinical eradication compared to prolonged 6-week intravenous courses (OVIVA trial), while significantly reducing central venous catheter complications.

2. Anatomy and Biomechanical Kinematics

Successful management of acute joint sepsis demands a thorough understanding of the microvascular synovial envelope, joint-specific intracapsular anatomy, and adjacent surgical access corridors.

Microvascular and Synovial Architecture

The synovium lines the non-cartilaginous surfaces of the joint cavity and consists of a cellular intimal layer (1 to 3 cells deep, comprising type A macrophage-like and type B fibroblast-like synoviocytes) overlying a loose, highly vascularized subintimal stroma. Crucially, the synovial intimal lining lacks an epithelial basement membrane. This physiological absence facilitates the rapid, unrestricted exchange of nutrients and fluids between the subsynovial capillary plexus and the articular cavity; however, it also renders the joint space exquisitely susceptible to hematogenous bacterial translocation during transient bacteremia.

Intracapsular Tamponade and Joint-Specific Corridors

As purulent exudate accumulates, intracapsular pressure rises exponentially. In closed spherical cavities such as the hip, intracapsular tamponade rapidly exceeds femoral head capillary perfusion pressure, precipitating acute epiphyseal ischemia and osteonecrosis. Consequently, patients reflexively hold infected joints in the resting posture of maximum intracapsular volume and compliance:

• Hip: Maintained in 30° to 45° of flexion, slight abduction, and external rotation (relaxing the iliofemoral ligament of Bigelow). Operative access utilizes the anterior (Smith-Petersen) corridor between sartorius (femoral nerve) and tensor fasciae latae (superior gluteal nerve) or the anterolateral (Watson-Jones) approach.
• Knee: Maintained in 30° to 40° of flexion (relaxing the posterior capsule and cruciate ligaments). Operative arthroscopy utilizes standard anteromedial and anterolateral parapatellar portals, with superomedial outflow.
• Shoulder: Maintained in adduction and internal rotation. Exposure utilizes the deltopectoral interval between the deltoid (axillary nerve) and pectoralis major (medial/lateral pectoral nerves).
• Ankle: Maintained in 10° to 15° of plantarflexion. Exposure utilizes anteromedial (medial to tibialis anterior) and anterolateral (lateral to peroneus tertius) portals.

Neurovascular Danger Zones

• Femoral Neurovascular Bundle: Traversed adjacent to the anterior hip joint capsule. Deep retractor placement across the anterior acetabular rim must remain strictly subcapsular and subperiosteal to prevent laceration or traction palsy of the femoral nerve and external iliac vessels.
• Popliteal Neurovascular Bundle: Located directly posterior to the central posterior capsule of the knee. Aggressive motorized shaver debridement across the posterior septum or uncontrolled capsular puncture risks catastrophic injury to the popliteal artery and tibial nerve.
• Axillary Nerve and Posterior Circumflex Humeral Artery: Bordering the inferior capsule of the glenohumeral joint through the quadrangular space. Inferior capsular releases or debridement must remain in direct contact with the glenoid rim to prevent iatrogenic neurotmesis.
• Superficial and Deep Peroneal Nerves: Cross the anterior ankle capsule; careful portal placement medial to tibialis anterior and lateral to peroneus tertius prevents cutaneous and motor nerve entrapment.

3. Pathogenesis and Microbiology

The pathogenesis of septic arthritis involves four distinct routes of bacterial inoculation into the synovial cavity:

• Hematogenous Seeding (>70%): The most common route in adults and children, resulting from transient bacteremia secondary to cutaneous lesions, dental procedures, urinary tract infections, or intravenous access lines.
• Direct Exogenous Inoculation (15%): Secondary to penetrating articular trauma, diagnostic arthrocentesis, intra-articular corticosteroid/viscosupplement injections, or surgical arthroscopy.
• Contiguous Spread (10%): Extension from adjacent metaphyseal osteomyelitis (predominantly in joints where the metaphysis is intracapsular: proximal femur, proximal humerus, radial neck, and distal fibula) or periarticular soft tissue abscesses.
• Iatrogenic / Post-Surgical (5%): Deep contamination during elective joint reconstructions or hardware placement.

Molecular Mechanisms of Chondrocyte Destruction

Once bacteria penetrate the joint, adherence to articular cartilage is mediated by Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs), such as fibronectin-binding protein, collagen adhesin (Cna), and clumping factors. Within hours of adherence, pathogen proliferation triggers a massive host immunological response, resulting in rapid chondrocyte apoptosis and extracellular matrix breakdown:

• Bacterial Toxins: Exotoxins, endotoxins, and superantigens directly kill chondrocytes and provoke pro-inflammatory cytokine cascades.
• Host Leukocyte Degranulation: Infiltrating polymorphonuclear neutrophils release matrix metalloproteinases (MMP-1, MMP-3, MMP-13), elastase, cathepsin G, and lysosomal acid hydrolases into the joint space.
• Matrix Depletion: Irreversible degradation of articular proteoglycans begins within 8 hours. Collagen fibril cleavage and structural architectural failure occur within 48 to 72 hours.
• Microvascular Tamponade: Purulent effusion increases intracapsular pressure, occluding subsynovial and intraosseous capillary flow, leading to cartilage ischemia, pannus formation, and subchondral bone necrosis.

Microbiological Etiology

4. Natural History and Epidemiology

The annual incidence of native joint septic arthritis in industrialized nations ranges from 2 to 10 cases per 100,000 person-years, escalating to 30 to 70 cases per 100,000 in high-risk subsets, including patients with rheumatoid arthritis, diabetes mellitus, or end-stage renal disease.

Demographics and Joint Distribution

The age distribution exhibits a bimodal incidence, peaking in children under 5 years of age and adults over 65 years. The knee is involved in over 50% of cases, followed by the hip (20%), shoulder (8%), ankle (7%), elbow (6%), and wrist (4%). Polyarticular involvement occurs in 10% to 15% of cases, almost exclusively in patients with underlying rheumatoid arthritis, systemic lupus erythematosus, or overwhelming bacteremic sepsis.

Prognosis and Morbidity

If untreated or if surgical decompression is delayed beyond 48 hours, septic arthritis leads inexorably to complete articular destruction, fibrous or bony ankylosis, pathological joint subluxation, and secondary osteoarthrosis. Modern in-hospital mortality remains significant at 7% to 15% for monoarticular disease and up to 30% for polyarticular sepsis. Among surviving patients, 30% to 50% experience permanent functional disability, persistent pain, or severe motion loss.

5. Clinical Presentation

Rapid clinical diagnosis requires a high index of suspicion, combining detailed history with precise, objective physical examination maneuvers.

Patient History

• Acute Pain Onset: Severe, unrelenting monoarticular pain present in 85% of cases (95% CI, 78%–90%). Pain is typically exacerbated by any active or passive motion.
• Joint Swelling: Rapid accumulation of tense joint effusion reported by 78% of patients (95% CI, 71%–85%).
• Systemic Symptoms: Fever is present in only 57% of confirmed presentations. The absence of fever, chills, or night sweats must never be used to rule out joint sepsis.
• Host Risk Profile: Inquire specifically regarding underlying rheumatoid disease, biologic immunosuppression, diabetes mellitus, history of crystal arthropathy, intravenous drug use, recent invasive procedures, and skin ulcers.

Physical Examination

Physical examination must systematically evaluate local signs of inflammation, effusion volume, and provocative motion tolerance:

• Inspection and Palpation: Tense, fluctuant articular effusion with overlying erythema and marked calor. Tenderness is diffuse across the entire joint perimeter rather than localized to specific ligaments or bursae.
• Active and Passive Motion: Global limitation of motion in all planes. Patients exhibit extreme muscular guarding and refusal to allow passive motion (pseudo-paralysis in infants).
• Hip Log-Roll Test: Gentle internal and external rotation of the extended lower extremity -> Severe groin pain and involuntary spasm [Sensitivity ~90%]. Differentiates intracapsular pathology from trochanteric bursitis or psoas abscess.
• Axial Loading Test: Percussion on the heel with the knee extended -> Acute exacerbation of joint pain [Sensitivity ~80%].

6. Imaging and Diagnostic Studies

Diagnostic evaluation follows an evidence-based hierarchy, prioritizing immediate synovial fluid aspiration alongside targeted imaging and inflammatory laboratory panels.

Synovial Fluid Analysis (The Diagnostic Gold Standard)

Arthrocentesis must be performed under strict sterile conditions before administering antimicrobials. Synovial fluid must be sent immediately for cell count and differential, Gram stain, polarized light microscopy, and aerobic/anaerobic cultures.

Serum Inflammatory Biomarkers

• Peripheral White Blood Cell Count (WBC): Sensitivity 90%, Specificity 36%. Leukocytosis is frequently absent in elderly or immunosuppressed patients; a normal count does not rule out septic arthritis.
• Erythrocyte Sedimentation Rate (ESR): Sensitivity 95%, Specificity 29%. Highly sensitive but non-specific screening marker with slow return to baseline (2 to 4 weeks).
• C-Reactive Protein (CRP): Sensitivity 77% to 85%, Specificity 53% to 65%. Rapid kinetic profile (peaks at 48 hours; half-life 19 hours), making it the primary objective marker for tracking clinical response to surgical drainage and antibiotic therapy.
• Serum Procalcitonin: Sensitivity 67%, Specificity >85%. Substantially superior to ESR/CRP for discriminating bacterial joint sepsis from acute gout, pseudogout, or rheumatoid flare.
• Blood Cultures: Two sets of peripheral blood cultures must be drawn prior to antibiotic administration; positive in 50% to 70% of hematogenous cases, providing pathogen identity when synovial fluid is culture-negative.

Radiographic and Advanced Imaging

• Plain Radiographs (AP and Lateral): Initial baseline imaging. Early findings are limited to soft tissue swelling, capsular distension, and displacement of periarticular fat pads. Radiographs rule out underlying fractures, foreign bodies, osteonecrosis, and chondrocalcinosis. Narrowing of the joint space and subchondral bony erosions are late signs indicating irreversible chondrolysis (>10–14 days).
• Ultrasonography: Modality of choice for detecting occult effusions in deep, non-palpable joints (hip, shoulder). Provides dynamic real-time needle guidance for diagnostic aspiration with >95% sensitivity for effusion detection.
• Magnetic Resonance Imaging (MRI): Reserved for diagnostic dilemmas, axial/sacroiliac joints, or evaluating suspected concomitant osteomyelitis or periarticular abscess. Demonstrates synovial thickening, intense post-contrast enhancement, and subchondral marrow edema with >95% sensitivity.

7. Classification & Risk Stratification

Validated classification and clinical prediction systems guide procedural selection and predict procedural failure in septic arthritis.

Gächter Arthroscopic Staging System

The Gächter staging system classifies joint sepsis based on intraoperative visual characteristics and histological progression, directly determining whether arthroscopic lavage is sufficient or open arthrotomy is indicated:

Kocher Clinical Prediction Rule for Pediatric Hip Sepsis

The Kocher criteria differentiate septic arthritis of the hip from benign transient synovitis in pediatric patients presenting with acute, non-traumatic irritable hip pain:

• 1. Inability to Bear Weight: Complete refusal to bear weight or walk on the affected limb.
• 2. Oral Temperature > 38.5°C: Measured core fever within the preceding 24 hours.
• 3. Erythrocyte Sedimentation Rate (ESR) ≥ 40 mm/h: Elevated baseline acute-phase reactant.
• 4. Serum White Blood Cell Count (WBC) > 12,000 /μL: Peripheral inflammatory leukocytosis.

Predicted Probability of Pediatric Hip Sepsis: 0 criteria = <0.2%; 1 criterion = 3.0%; 2 criteria = 40.0%; 3 criteria = 67.3% to 93.1%; 4 criteria = 93.0% to 99.6%. Note: The addition of C-reactive protein (CRP > 20 mg/L) as a 5th independent predictor increases diagnostic specificity to 98% (Caird et al.).

8. Treatment and Management Algorithms

Definitive eradication of joint sepsis rests on the dual pillars of emergency joint decompression and targeted bactericidal antimicrobial therapy.

Medical and Antimicrobial Therapy

Immediately following diagnostic arthrocentesis, empiric intravenous bactericidal therapy must be initiated without waiting for Gram stain or culture confirmation:

• Initial Empiric Adult Regimen: Vancomycin (15 to 20 mg/kg IV q12h, adjusted to serum trough 15–20 μg/mL or AUC/MIC ≥400) to cover methicillin-resistant S. aureus (MRSA) PLUS a 3rd-generation cephalosporin (Ceftriaxone 2 g IV q24h) or antipseudomonal beta-lactam (Cefepime 2 g IV q8h or Piperacillin-Tazobactam 4.5 g IV q6h) if the patient has risk factors for Gram-negative sepsis (elderly, urosepsis, IV drug use, or neutropenia).
• Culture-Directed Adjustment: Once pathogen identification and susceptibilities are confirmed, narrow therapy:
  • MSSA: Cefazolin (2 g IV q8h) or Oxacillin/Nafcillin (2 g IV q4h) — superior bactericidal kill rate and clinical outcomes compared to vancomycin.
  • MRSA: Vancomycin or Daptomycin (8–10 mg/kg IV q24h).
  • Streptococcus spp.: Ceftriaxone (2 g IV q24h) or Penicillin G (24 million units/day continuous infusion).
  • Gram-Negative Enterobacteriaceae: Ceftriaxone (2 g IV q24h) or Ciprofloxacin (750 mg PO BID / 400 mg IV q12h).
• Route and Duration (OVIVA Paradigm): Historically, 4 to 6 weeks of intravenous therapy was mandated. Level I evidence from the OVIVA randomized controlled trial demonstrates that an early step-down to highly bioavailable oral antimicrobials (e.g., fluoroquinolones, high-dose amoxicillin, linezolid, rifampin combinations) after 1 to 2 weeks of IV therapy is non-inferior to continuous 6-week IV regimens, provided the following criteria are met: clinical defervescence, marked reduction in CRP, control of local swelling/effusion, and an identified pathogen susceptible to oral agents. Total duration is typically 3 to 4 weeks for uncomplicated native joint sepsis, extending to 6 weeks if accompanied by adjacent osteomyelitis.

Operative Decompression and Lavage

The primary goals of surgery are: (1) evacuation of all purulent, fibrinous exudate; (2) reduction of intra-articular pressure to restore microvascular capillary perfusion; (3) removal of destructive bacterial proteases and inflammatory cytokines; and (4) radical debridement of hypertrophic synovium and pseudomembranes harboring bacterial biofilms.

• Arthroscopic Lavage and Debridement: Primary modality for the knee, shoulder, and ankle (Gächter Stages I–III). Utilizes high-volume copiously warmed saline irrigation (>9–12 L), mechanical breakdown of intra-articular fibrinous septations, partial synovectomy using motorized shavers, and placement of large-bore closed suction drains without continuous irrigation. Minimizes surgical soft-tissue trauma and permits early active rehabilitation.
• Open Arthrotomy and Radical Synovectomy: Mandatory for: (1) pediatric septic hip (to immediately relieve capsular tamponade and prevent avascular necrosis of the femoral capital epiphysis); (2) Gächter Stage IV disease with subchondral bone invasion or extra-articular phlegmon; (3) failed clinical or biochemical response after 48 to 72 hours following initial arthroscopy; and (4) anatomically complex joints with loculated posterior compartments inaccessible to arthroscopy.
• Serial Needle Aspiration: Reserved exclusively for neonates with non-hip joints, small peripheral joints (MCP, IP joints), or medically moribund patients unable to undergo general anesthesia. If the joint cannot be completely aspirated or if clinical signs and inflammatory markers fail to improve within 24 to 48 hours, surgical decompression is mandatory.

Indications & Contraindications

Absolute Indications for Emergency Surgical Decompression:

• Frank purulent synovial aspirate or positive synovial fluid Gram stain.
• Pediatric septic hip (Kocher score ≥3 or positive ultrasound-guided aspirate).
• Loculated effusions, phlegmon, or extensive fibrinous debris visible on ultrasonography or MRI.
• Failure to improve clinically (persistent fever, pain, elevated CRP) after 48 hours of medical/aspiration therapy.

Contraindications to Isolated Arthroscopic Lavage:

• Gächter Stage IV advanced bone and cartilage destruction (requires open radical debridement).
• Extensive periarticular soft tissue abscess tracking outside the joint capsule.

9. Outcomes and Prognostic Factors

Functional recovery is intimately linked to the interval between symptom onset and definitive surgical decompression. When decompression is achieved within 24 to 48 hours of onset, 75% to 85% of patients achieve complete resolution with preserved joint kinematics and pain-free function.

Validated Predictors of Treatment Failure

Independent clinical predictors associated with persistent infection, recurrent surgery, or permanent joint impairment include:

• Delay in Surgical Drainage > 4 Days: Correlates with a fourfold increase in irreversible cartilage loss and secondary osteoarthrosis.
• Age > 65 Years: Associated with impaired host immunity, blunted local tissue repair, and elevated 90-day systemic mortality.
• Pre-Existing Joint Pathology: Underlying rheumatoid arthritis or severe osteoarthritis provides altered cartilage architecture that accelerates bacterial adhesion and destruction.
• Virulent Pathogens: Infection caused by Staphylococcus aureus (particularly MRSA) or Gram-negative bacilli yields significantly higher reoperation and arthrofibrosis rates compared to streptococcal or gonococcal etiologies.

10. Complications

Complications are categorized by temporal occurrence, ranging from acute limb-threatening emergencies to chronic functional impairments:

11. Pearls and Pitfalls

Advanced clinical pearls and common diagnostic pitfalls essential for senior clinicians and resident trainees:

• The “Crystal Fallacy” Pitfall: Identifying birefringent intracellular crystals on polarized light microscopy does not exclude septic arthritis. True concurrent crystal disease (gout or pseudogout) and bacterial sepsis occur in 5% to 10% of cases. Always send crystal-positive synovial fluid for cell count and microbiological cultures.
• The “Fever Trap” Pitfall: Do not rely on fever or elevated peripheral WBC to rule out infection. Over 40% of adult patients with culture-proven native septic arthritis are afebrile upon presentation, particularly those with chronic renal failure, cirrhosis, or biologic therapy.
• Blood Culture Bottle Inoculation Pearl: Synovial fluid culture yield increases significantly (from ~65% to >85%–90%) when aspirated fluid is immediately inoculated directly into aerobic and anaerobic pediatric or adult blood culture bottles at the bedside.
• Dry Tap Diagnostic Pearl: If clinical suspicion is high but arthrocentesis yields a “dry tap,” do not assume absence of effusion. Utilize ultrasonography to confirm needle placement. If no fluid is present in an inflamed joint, consider bursitis, periarticular phlegmon, or tenosynovitis.
• Pediatric Hip Emergency Pearl: A child with an irritable hip who meets 3 or 4 Kocher criteria must be treated as having a surgical emergency. Do not wait for formal culture results before proceeding with ultrasound-guided aspiration and immediate operating room arthrotomy.

12. Controversies in Management

Modern orthopaedic surgery continues to debate several key management controversies in native joint septic arthritis:

• Arthroscopy versus Open Arthrotomy: In adult knee and shoulder sepsis, multiple comparative trials demonstrate that arthroscopic debridement achieves clinical cure rates comparable to open arthrotomy in Gächter Stages I–III, while offering significantly less postoperative pain, reduced hospital length of stay, and faster restoration of motion. However, in Gächter Stage IV or advanced loculated disease, open conversion remains mandatory.
• Optimal Antibiotic Duration & Early Oral Switch: Historical dogma dictated 4 to 6 weeks of continuous intravenous therapy. Following the landmark OVIVA trial (Li et al., NEJM 2019), high-level evidence supports early oral transition after 7 to 14 days of initial IV treatment, challenging traditional prolonged outpatient parenteral antibiotic therapy (OPAT) models.
• Continuous Postoperative Joint Irrigation: Continuous closed-circuit irrigation with antibiotic-containing solutions has largely been abandoned. High-level evidence indicates that continuous inflow-outflow systems fail to decrease reoperation rates and risk chemical synovitis and secondary nosocomial superinfection. Simple closed-suction drainage without instillation is preferred.
• Adjuvant Corticosteroids in Pediatric Sepsis: Emerging clinical trials evaluate the use of low-dose adjuvant dexamethasone administered alongside intravenous antibiotics in pediatric septic arthritis. Preliminary findings suggest accelerated symptom resolution, shorter hospitalization, and reduced residual chondral damage without increasing bacteremic recurrence, although widespread consensus is pending further large multicenter trials.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Margaretten ME, Kohlwes J, Moore D et al. Does this adult patient have septic arthritis?. JAMA. 2007. doi:10.1001/jama.297.13.1478 [Level I: Systematic Review & Meta-Analysis]
• Carpenter CR, Schuur JD, Everett WW et al. Evidence-based diagnostics: adult septic arthritis. Acad Emerg Med. 2011. doi:10.1111/j.1553-2712.2011.01121.x [Level I: Systematic Review / Meta-Analysis]
• Kocher MS, Mandiga R, Zurakowski D et al. Validation of a clinical prediction rule for the differentiation between septic arthritis and transient synovitis of the hip in children. J Bone Joint Surg Am. 2004. doi:10.2106/00004623-200408000-00005 [Level II: Prospective Validation Study]
• Li HK, Rombach I, Zambellas R et al. Oral versus Intravenous Antibiotics for Bone and Joint Infection. N Engl J Med. 2019. doi:10.1056/NEJMoa1710926 [Level I: Multicenter Randomized Controlled Trial]
• Benito N, Martínez-Pastor JC, Lora-Tamayo J et al. Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT. Enferm Infecc Microbiol Clin (Engl Ed). 2024. doi:10.1016/j.eimce.2023.07.007 [Level I: Clinical Practice Guidelines / Systematic Review]

15. Master Class Pro-Tip

“In the management of native joint septic arthritis, the surgeon’s greatest adversary is diagnostic delay. Joint aspiration must always precede the first dose of antimicrobial therapy unless the patient is in decompensated septic shock. When arthroscopic lavage is undertaken, copious mechanical irrigation alone is inadequate; all dense fibrinous pseudomembranes and organized loculations must be systematically excised with a motorized shaver, as bacterial microcolonies sequestered within fibrin matrix are impervious to circulating systemic antibiotics. If a patient exhibits persistent fever, non-weight-bearing, or failure of serum C-reactive protein to decline by 50% within 48 to 72 hours following initial decompression, do not change antibiotics blindly—return promptly to the operating room for repeat surgical clearance.”

Master Class Surgical Pearl: Joint Decompression and Diagnostic Discipline